DEA vs SBRA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SBRA Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sabra Healthcare REIT, Inc. (SBRA) driven by superior Valuation, Growth & Margin, Momentum & Technical while DEA counters with relative strength in Options & Structure. Fundamentally, DEA trades at 46.1x Forward P/E with 25.2% operating margin (+8.8% YoY revenue) versus SBRA at 30.4x Forward P/E and 18.4% operating margin (+31.6% YoY). In options structure, DEA sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro) against SBRA sits in CONSOLIDATION (17th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)
| Period | DEA Revenue | SBRA Revenue | DEA Op. Margin | SBRA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| Q3 '25 | $340M | $760M | 25.0% | 31.3% | SBRA |
| Q4 '25 | $350M | $850M | 25.0% | 30.5% | SBRA |
| Q1 '26 | $370M | $890M | 22.5% | 30.8% | SBRA |
| Q2 '26 | $370M | $940M | 24.4% | -13.6% | DEA |
| Q3 '26 | $370M | $1.00B | 26.0% | 25.6% | DEA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DEA | SBRA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.1B | $5.4B | Larger Scale | SBRA |
| Trailing P/E Ratio Valuation | 76.1x | 75.7x | Lower Multiple | SBRA |
| Forward P/E Ratio Valuation | 46.1x | 30.4x | Lower Multiple | SBRA |
| Revenue Growth (YoY) Growth | +8.8% | +31.6% | Higher Growth | SBRA |
| Operating Margin (TTM) Profitability | 25.2% | 18.4% | Higher Margin | DEA |
| Net Profit Margin Profitability | 3.9% | 7.7% | Higher Margin | SBRA |
| Return on Equity (ROE) Capital Efficiency | 1.1% | 2.5% | Higher ROE | SBRA |
| 52-Week Range Position Momentum | 22% ($21โ$26) | 52% ($18โ$23) | Stronger Trend | SBRA |
| Beta / 30D Volatility Risk Regime | 0.31ฮฒ ยท 26% Vol | 0.00ฮฒ ยท 30% Vol | Lower Realized Risk | DEA |
| Unified Institutional Score Composite Signal | 45.1 / 100 (HOLD) | 57.4 / 100 (HOLD) | Higher Composite | SBRA |